The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Pet Anthelmintic Drugs Market 2024 by Company, Regions, Type and Application, Forecast to 2028
Synopsis
The Pet Anthelmintic Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Pet Anthelmintic Drugs market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Dog accounting for % of the Pet Anthelmintic Drugs global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While External segment is altered to a % CAGR between 2022 and 2028.
Global key companies of Pet Anthelmintic Drugs include Elanco, Boehringer Ingelheim, Ceva Sante Animale, Chanelle Group, and Dechra, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Pet Anthelmintic Drugs market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
External
Internal
Composite
Injection
Market segment by Application, can be divided into
Dog
Cat
Others
Market segment by players, this report covers
Elanco
Boehringer Ingelheim
Ceva Sante Animale
Chanelle Group
Dechra
Durvet
First Priority
Jeffers
Manna Pro Products
Merck Animal Health
Ourofino
TTK Healthcare
Vetoquinol
Virbac
Zoetis
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Pet Anthelmintic Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Pet Anthelmintic Drugs, with revenue, gross margin and global market share of Pet Anthelmintic Drugs from 2019 to 2022.
Chapter 3, the Pet Anthelmintic Drugs competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Pet Anthelmintic Drugs market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Pet Anthelmintic Drugs research findings and conclusion, appendix and data source.
Geographical Area
Global
The Pet Anthelmintic Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Pet Anthelmintic Drugs market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Dog accounting for % of the Pet Anthelmintic Drugs global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While External segment is altered to a % CAGR between 2022 and 2028.
Global key companies of Pet Anthelmintic Drugs include Elanco, Boehringer Ingelheim, Ceva Sante Animale, Chanelle Group, and Dechra, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Pet Anthelmintic Drugs market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
External
Internal
Composite
Injection
Market segment by Application, can be divided into
Dog
Cat
Others
Market segment by players, this report covers
Elanco
Boehringer Ingelheim
Ceva Sante Animale
Chanelle Group
Dechra
Durvet
First Priority
Jeffers
Manna Pro Products
Merck Animal Health
Ourofino
TTK Healthcare
Vetoquinol
Virbac
Zoetis
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Pet Anthelmintic Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Pet Anthelmintic Drugs, with revenue, gross margin and global market share of Pet Anthelmintic Drugs from 2019 to 2022.
Chapter 3, the Pet Anthelmintic Drugs competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Pet Anthelmintic Drugs market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Pet Anthelmintic Drugs research findings and conclusion, appendix and data source.
Geographical Area
Global
Index1 Market Overview
1.1 Product Overview and Scope of Pet Anthelmintic Drugs
1.2 Classification of Pet Anthelmintic Drugs by Type
1.2.1 Overview: Global Pet Anthelmintic Drugs Market Size by Type: 2017 Versus 2021 Versus 2028
1.2.2 Global Pet Anthelmintic Drugs Revenue Market Share by Type in 2021
1.2.3 External
1.2.4 Internal
1.2.5 Composite
1.2.6 Injection
1.3 Global Pet Anthelmintic Drugs Market by Application
1.3.1 Overview: Global Pet Anthelmintic Drugs Market Size by Application: 2017 Versus 2021 Versus 2028
1.3.2 Dog
1.3.3 Cat
1.3.4 Others
1.4 Global Pet Anthelmintic Drugs Market Size & Forecast
1.5 Global Pet Anthelmintic Drugs Market Size and Forecast by Region
1.5.1 Global Pet Anthelmintic Drugs Market Size by Region: 2017 VS 2021 VS 2028
1.5.2 Global Pet Anthelmintic Drugs Market Size by Region, (2017-2022)
1.5.3 North America Pet Anthelmintic Drugs Market Size and Prospect (2017-2028)
1.5.4 Europe Pet Anthelmintic Drugs Market Size and Prospect (2017-2028)
1.5.5 Asia-Pacific Pet Anthelmintic Drugs Market Size and Prospect (2017-2028)
1.5.6 South America Pet Anthelmintic Drugs Market Size and Prospect (2017-2028)
1.5.7 Middle East and Africa Pet Anthelmintic Drugs Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
1.6.1 Pet Anthelmintic Drugs Market Drivers
1.6.2 Pet Anthelmintic Drugs Market Restraints
1.6.3 Pet Anthelmintic Drugs Trends Analysis
2 Company Profiles
2.1 Elanco
2.1.1 Elanco Details
2.1.2 Elanco Major Business
2.1.3 Elanco Pet Anthelmintic Drugs Product and Solutions
2.1.4 Elanco Pet Anthelmintic Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.1.5 Elanco Recent Developments and Future Plans
2.2 Boehringer Ingelheim
2.2.1 Boehringer Ingelheim Details
2.2.2 Boehringer Ingelheim Major Business
2.2.3 Boehringer Ingelheim Pet Anthelmintic Drugs Product and Solutions
2.2.4 Boehringer Ingelheim Pet Anthelmintic Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2.5 Boehringer Ingelheim Recent Developments and Future Plans
2.3 Ceva Sante Animale
2.3.1 Ceva Sante Animale Details
2.3.2 Ceva Sante Animale Major Business
2.3.3 Ceva Sante Animale Pet Anthelmintic Drugs Product and Solutions
2.3.4 Ceva Sante Animale Pet Anthelmintic Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3.5 Ceva Sante Animale Recent Developments and Future Plans
2.4 Chanelle Group
2.4.1 Chanelle Group Details
2.4.2 Chanelle Group Major Business
2.4.3 Chanelle Group Pet Anthelmintic Drugs Product and Solutions
2.4.4 Chanelle Group Pet Anthelmintic Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4.5 Chanelle Group Recent Developments and Future Plans
2.5 Dechra
2.5.1 Dechra Details
2.5.2 Dechra Major Business
2.5.3 Dechra Pet Anthelmintic Drugs Product and Solutions
2.5.4 Dechra Pet Anthelmintic Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5.5 Dechra Recent Developments and Future Plans
2.6 Durvet
2.6.1 Durvet Details
2.6.2 Durvet Major Business
2.6.3 Durvet Pet Anthelmintic Drugs Product and Solutions
2.6.4 Durvet Pet Anthelmintic Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6.5 Durvet Recent Developments and Future Plans
2.7 First Priority
2.7.1 First Priority Details
2.7.2 First Priority Major Business
2.7.3 First Priority Pet Anthelmintic Drugs Product and Solutions
2.7.4 First Priority Pet Anthelmintic Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7.5 First Priority Recent Developments and Future Plans
2.8 Jeffers
2.8.1 Jeffers Details
2.8.2 Jeffers Major Business
2.8.3 Jeffers Pet Anthelmintic Drugs Product and Solutions
2.8.4 Jeffers Pet Anthelmintic Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8.5 Jeffers Recent Developments and Future Plans
2.9 Manna Pro Products
2.9.1 Manna Pro Products Details
2.9.2 Manna Pro Products Major Business
2.9.3 Manna Pro Products Pet Anthelmintic Drugs Product and Solutions
2.9.4 Manna Pro Products Pet Anthelmintic Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9.5 Manna Pro Products Recent Developments and Future Plans
2.10 Merck Animal Health
2.10.1 Merck Animal Health Details
2.10.2 Merck Animal Health Major Business
2.10.3 Merck Animal Health Pet Anthelmintic Drugs Product and Solutions
2.10.4 Merck Animal Health Pet Anthelmintic Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10.5 Merck Animal Health Recent Developments and Future Plans
2.11 Ourofino
2.11.1 Ourofino Details
2.11.2 Ourofino Major Business
2.11.3 Ourofino Pet Anthelmintic Drugs Product and Solutions
2.11.4 Ourofino Pet Anthelmintic Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11.5 Ourofino Recent Developments and Future Plans
2.12 TTK Healthcare
2.12.1 TTK Healthcare Details
2.12.2 TTK Healthcare Major Business
2.12.3 TTK Healthcare Pet Anthelmintic Drugs Product and Solutions
2.12.4 TTK Healthcare Pet Anthelmintic Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12.5 TTK Healthcare Recent Developments and Future Plans
2.13 Vetoquinol
2.13.1 Vetoquinol Details
2.13.2 Vetoquinol Major Business
2.13.3 Vetoquinol Pet Anthelmintic Drugs Product and Solutions
2.13.4 Vetoquinol Pet Anthelmintic Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13.5 Vetoquinol Recent Developments and Future Plans
2.14 Virbac
2.14.1 Virbac Details
2.14.2 Virbac Major Business
2.14.3 Virbac Pet Anthelmintic Drugs Product and Solutions
2.14.4 Virbac Pet Anthelmintic Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14.5 Virbac Recent Developments and Future Plans
2.15 Zoetis
2.15.1 Zoetis Details
2.15.2 Zoetis Major Business
2.15.3 Zoetis Pet Anthelmintic Drugs Product and Solutions
2.15.4 Zoetis Pet Anthelmintic Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.15.5 Zoetis Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Pet Anthelmintic Drugs Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
3.2.1 Top 3 Pet Anthelmintic Drugs Players Market Share in 2021
3.2.2 Top 10 Pet Anthelmintic Drugs Players Market Share in 2021
3.2.3 Market Competition Trend
3.3 Pet Anthelmintic Drugs Players Head Office, Products and Services Provided
3.4 Pet Anthelmintic Drugs Mergers & Acquisitions
3.5 Pet Anthelmintic Drugs New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Pet Anthelmintic Drugs Revenue and Market Share by Type (2017-2022)
4.2 Global Pet Anthelmintic Drugs Market Forecast by Type (2023-2028)
5 Market Size Segment by Application
5.1 Global Pet Anthelmintic Drugs Revenue Market Share by Application (2017-2022)
5.2 Global Pet Anthelmintic Drugs Market Forecast by Application (2023-2028)
6 North America by Country, by Type, and by Application
6.1 North America Pet Anthelmintic Drugs Revenue by Type (2017-2028)
6.2 North America Pet Anthelmintic Drugs Revenue by Application (2017-2028)
6.3 North America Pet Anthelmintic Drugs Market Size by Country
6.3.1 North America Pet Anthelmintic Drugs Revenue by Country (2017-2028)
6.3.2 United States Pet Anthelmintic Drugs Market Size and Forecast (2017-2028)
6.3.3 Canada Pet Anthelmintic Drugs Market Size and Forecast (2017-2028)
6.3.4 Mexico Pet Anthelmintic Drugs Market Size and Forecast (2017-2028)
7 Europe by Country, by Type, and by Application
7.1 Europe Pet Anthelmintic Drugs Revenue by Type (2017-2028)
7.2 Europe Pet Anthelmintic Drugs Revenue by Application (2017-2028)
7.3 Europe Pet Anthelmintic Drugs Market Size by Country
7.3.1 Europe Pet Anthelmintic Drugs Revenue by Country (2017-2028)
7.3.2 Germany Pet Anthelmintic Drugs Market Size and Forecast (2017-2028)
7.3.3 France Pet Anthelmintic Drugs Market Size and Forecast (2017-2028)
7.3.4 United Kingdom Pet Anthelmintic Drugs Market Size and Forecast (2017-2028)
7.3.5 Russia Pet Anthelmintic Drugs Market Size and Forecast (2017-2028)
7.3.6 Italy Pet Anthelmintic Drugs Market Size and Forecast (2017-2028)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Pet Anthelmintic Drugs Revenue by Type (2017-2028)
8.2 Asia-Pacific Pet Anthelmintic Drugs Revenue by Application (2017-2028)
8.3 Asia-Pacific Pet Anthelmintic Drugs Market Size by Region
8.3.1 Asia-Pacific Pet Anthelmintic Drugs Revenue by Region (2017-2028)
8.3.2 China Pet Anthelmintic Drugs Market Size and Forecast (2017-2028)
8.3.3 Japan Pet Anthelmintic Drugs Market Size and Forecast (2017-2028)
8.3.4 South Korea Pet Anthelmintic Drugs Market Size and Forecast (2017-2028)
8.3.5 India Pet Anthelmintic Drugs Market Size and Forecast (2017-2028)
8.3.6 Southeast Asia Pet Anthelmintic Drugs Market Size and Forecast (2017-2028)
8.3.7 Australia Pet Anthelmintic Drugs Market Size and Forecast (2017-2028)
9 South America by Country, by Type, and by Application
9.1 South America Pet Anthelmintic Drugs Revenue by Type (2017-2028)
9.2 South America Pet Anthelmintic Drugs Revenue by Application (2017-2028)
9.3 South America Pet Anthelmintic Drugs Market Size by Country
9.3.1 South America Pet Anthelmintic Drugs Revenue by Country (2017-2028)
9.3.2 Brazil Pet Anthelmintic Drugs Market Size and Forecast (2017-2028)
9.3.3 Argentina Pet Anthelmintic Drugs Market Size and Forecast (2017-2028)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Pet Anthelmintic Drugs Revenue by Type (2017-2028)
10.2 Middle East & Africa Pet Anthelmintic Drugs Revenue by Application (2017-2028)
10.3 Middle East & Africa Pet Anthelmintic Drugs Market Size by Country
10.3.1 Middle East & Africa Pet Anthelmintic Drugs Revenue by Country (2017-2028)
10.3.2 Turkey Pet Anthelmintic Drugs Market Size and Forecast (2017-2028)
10.3.3 Saudi Arabia Pet Anthelmintic Drugs Market Size and Forecast (2017-2028)
10.3.4 UAE Pet Anthelmintic Drugs Market Size and Forecast (2017-2028)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
List of TablesList of Tables
Table 1. Global Pet Anthelmintic Drugs Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global Pet Anthelmintic Drugs Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Market Pet Anthelmintic Drugs Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
Table 4. Global Pet Anthelmintic Drugs Revenue (USD Million) by Region (2017-2022)
Table 5. Global Pet Anthelmintic Drugs Revenue Market Share by Region (2023-2028)
Table 6. Elanco Corporate Information, Head Office, and Major Competitors
Table 7. Elanco Major Business
Table 8. Elanco Pet Anthelmintic Drugs Product and Solutions
Table 9. Elanco Pet Anthelmintic Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 10. Boehringer Ingelheim Corporate Information, Head Office, and Major Competitors
Table 11. Boehringer Ingelheim Major Business
Table 12. Boehringer Ingelheim Pet Anthelmintic Drugs Product and Solutions
Table 13. Boehringer Ingelheim Pet Anthelmintic Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 14. Ceva Sante Animale Corporate Information, Head Office, and Major Competitors
Table 15. Ceva Sante Animale Major Business
Table 16. Ceva Sante Animale Pet Anthelmintic Drugs Product and Solutions
Table 17. Ceva Sante Animale Pet Anthelmintic Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 18. Chanelle Group Corporate Information, Head Office, and Major Competitors
Table 19. Chanelle Group Major Business
Table 20. Chanelle Group Pet Anthelmintic Drugs Product and Solutions
Table 21. Chanelle Group Pet Anthelmintic Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 22. Dechra Corporate Information, Head Office, and Major Competitors
Table 23. Dechra Major Business
Table 24. Dechra Pet Anthelmintic Drugs Product and Solutions
Table 25. Dechra Pet Anthelmintic Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 26. Durvet Corporate Information, Head Office, and Major Competitors
Table 27. Durvet Major Business
Table 28. Durvet Pet Anthelmintic Drugs Product and Solutions
Table 29. Durvet Pet Anthelmintic Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 30. First Priority Corporate Information, Head Office, and Major Competitors
Table 31. First Priority Major Business
Table 32. First Priority Pet Anthelmintic Drugs Product and Solutions
Table 33. First Priority Pet Anthelmintic Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 34. Jeffers Corporate Information, Head Office, and Major Competitors
Table 35. Jeffers Major Business
Table 36. Jeffers Pet Anthelmintic Drugs Product and Solutions
Table 37. Jeffers Pet Anthelmintic Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 38. Manna Pro Products Corporate Information, Head Office, and Major Competitors
Table 39. Manna Pro Products Major Business
Table 40. Manna Pro Products Pet Anthelmintic Drugs Product and Solutions
Table 41. Manna Pro Products Pet Anthelmintic Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 42. Merck Animal Health Corporate Information, Head Office, and Major Competitors
Table 43. Merck Animal Health Major Business
Table 44. Merck Animal Health Pet Anthelmintic Drugs Product and Solutions
Table 45. Merck Animal Health Pet Anthelmintic Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 46. Ourofino Corporate Information, Head Office, and Major Competitors
Table 47. Ourofino Major Business
Table 48. Ourofino Pet Anthelmintic Drugs Product and Solutions
Table 49. Ourofino Pet Anthelmintic Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 50. TTK Healthcare Corporate Information, Head Office, and Major Competitors
Table 51. TTK Healthcare Major Business
Table 52. TTK Healthcare Pet Anthelmintic Drugs Product and Solutions
Table 53. TTK Healthcare Pet Anthelmintic Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 54. Vetoquinol Corporate Information, Head Office, and Major Competitors
Table 55. Vetoquinol Major Business
Table 56. Vetoquinol Pet Anthelmintic Drugs Product and Solutions
Table 57. Vetoquinol Pet Anthelmintic Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 58. Virbac Corporate Information, Head Office, and Major Competitors
Table 59. Virbac Major Business
Table 60. Virbac Pet Anthelmintic Drugs Product and Solutions
Table 61. Virbac Pet Anthelmintic Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 62. Zoetis Corporate Information, Head Office, and Major Competitors
Table 63. Zoetis Major Business
Table 64. Zoetis Pet Anthelmintic Drugs Product and Solutions
Table 65. Zoetis Pet Anthelmintic Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 66. Global Pet Anthelmintic Drugs Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
Table 67. Global Pet Anthelmintic Drugs Revenue Share by Players (2019, 2020, 2021, and 2022)
Table 68. Breakdown of Pet Anthelmintic Drugs by Company Type (Tier 1, Tier 2 and Tier 3)
Table 69. Pet Anthelmintic Drugs Players Head Office, Products and Services Provided
Table 70. Pet Anthelmintic Drugs Mergers & Acquisitions in the Past Five Years
Table 71. Pet Anthelmintic Drugs New Entrants and Expansion Plans
Table 72. Global Pet Anthelmintic Drugs Revenue (USD Million) by Type (2017-2022)
Table 73. Global Pet Anthelmintic Drugs Revenue Share by Type (2017-2022)
Table 74. Global Pet Anthelmintic Drugs Revenue Forecast by Type (2023-2028)
Table 75. Global Pet Anthelmintic Drugs Revenue by Application (2017-2022)
Table 76. Global Pet Anthelmintic Drugs Revenue Forecast by Application (2023-2028)
Table 77. North America Pet Anthelmintic Drugs Revenue by Type (2017-2022) & (USD Million)
Table 78. North America Pet Anthelmintic Drugs Revenue by Type (2023-2028) & (USD Million)
Table 79. North America Pet Anthelmintic Drugs Revenue by Application (2017-2022) & (USD Million)
Table 80. North America Pet Anthelmintic Drugs Revenue by Application (2023-2028) & (USD Million)
Table 81. North America Pet Anthelmintic Drugs Revenue by Country (2017-2022) & (USD Million)
Table 82. North America Pet Anthelmintic Drugs Revenue by Country (2023-2028) & (USD Million)
Table 83. Europe Pet Anthelmintic Drugs Revenue by Type (2017-2022) & (USD Million)
Table 84. Europe Pet Anthelmintic Drugs Revenue by Type (2023-2028) & (USD Million)
Table 85. Europe Pet Anthelmintic Drugs Revenue by Application (2017-2022) & (USD Million)
Table 86. Europe Pet Anthelmintic Drugs Revenue by Application (2023-2028) & (USD Million)
Table 87. Europe Pet Anthelmintic Drugs Revenue by Country (2017-2022) & (USD Million)
Table 88. Europe Pet Anthelmintic Drugs Revenue by Country (2023-2028) & (USD Million)
Table 89. Asia-Pacific Pet Anthelmintic Drugs Revenue by Type (2017-2022) & (USD Million)
Table 90. Asia-Pacific Pet Anthelmintic Drugs Revenue by Type (2023-2028) & (USD Million)
Table 91. Asia-Pacific Pet Anthelmintic Drugs Revenue by Application (2017-2022) & (USD Million)
Table 92. Asia-Pacific Pet Anthelmintic Drugs Revenue by Application (2023-2028) & (USD Million)
Table 93. Asia-Pacific Pet Anthelmintic Drugs Revenue by Region (2017-2022) & (USD Million)
Table 94. Asia-Pacific Pet Anthelmintic Drugs Revenue by Region (2023-2028) & (USD Million)
Table 95. South America Pet Anthelmintic Drugs Revenue by Type (2017-2022) & (USD Million)
Table 96. South America Pet Anthelmintic Drugs Revenue by Type (2023-2028) & (USD Million)
Table 97. South America Pet Anthelmintic Drugs Revenue by Application (2017-2022) & (USD Million)
Table 98. South America Pet Anthelmintic Drugs Revenue by Application (2023-2028) & (USD Million)
Table 99. South America Pet Anthelmintic Drugs Revenue by Country (2017-2022) & (USD Million)
Table 100. South America Pet Anthelmintic Drugs Revenue by Country (2023-2028) & (USD Million)
Table 101. Middle East & Africa Pet Anthelmintic Drugs Revenue by Type (2017-2022) & (USD Million)
Table 102. Middle East & Africa Pet Anthelmintic Drugs Revenue by Type (2023-2028) & (USD Million)
Table 103. Middle East & Africa Pet Anthelmintic Drugs Revenue by Application (2017-2022) & (USD Million)
Table 104. Middle East & Africa Pet Anthelmintic Drugs Revenue by Application (2023-2028) & (USD Million)
Table 105. Middle East & Africa Pet Anthelmintic Drugs Revenue by Country (2017-2022) & (USD Million)
Table 106. Middle East & Africa Pet Anthelmintic Drugs Revenue by Country (2023-2028) & (USD Million)
List of Figures
Figure 1. Pet Anthelmintic Drugs Picture
Figure 2. Global Pet Anthelmintic Drugs Revenue Market Share by Type in 2021
Figure 3. External
Figure 4. Internal
Figure 5. Composite
Figure 6. Injection
Figure 7. Pet Anthelmintic Drugs Revenue Market Share by Application in 2021
Figure 8. Dog Picture
Figure 9. Cat Picture
Figure 10. Others Picture
Figure 11. Global Pet Anthelmintic Drugs Market Size, (USD Million): 2017 VS 2021 VS 2028
Figure 12. Global Pet Anthelmintic Drugs Revenue and Forecast (2017-2028) & (USD Million)
Figure 13. Global Pet Anthelmintic Drugs Revenue Market Share by Region (2017-2028)
Figure 14. Global Pet Anthelmintic Drugs Revenue Market Share by Region in 2021
Figure 15. North America Pet Anthelmintic Drugs Revenue (USD Million) and Growth Rate (2017-2028)
Figure 16. Europe Pet Anthelmintic Drugs Revenue (USD Million) and Growth Rate (2017-2028)
Figure 17. Asia-Pacific Pet Anthelmintic Drugs Revenue (USD Million) and Growth Rate (2017-2028)
Figure 18. South America Pet Anthelmintic Drugs Revenue (USD Million) and Growth Rate (2017-2028)
Figure 19. Middle East and Africa Pet Anthelmintic Drugs Revenue (USD Million) and Growth Rate (2017-2028)
Figure 20. Pet Anthelmintic Drugs Market Drivers
Figure 21. Pet Anthelmintic Drugs Market Restraints
Figure 22. Pet Anthelmintic Drugs Market Trends
Figure 23. Elanco Recent Developments and Future Plans
Figure 24. Boehringer Ingelheim Recent Developments and Future Plans
Figure 25. Ceva Sante Animale Recent Developments and Future Plans
Figure 26. Chanelle Group Recent Developments and Future Plans
Figure 27. Dechra Recent Developments and Future Plans
Figure 28. Durvet Recent Developments and Future Plans
Figure 29. First Priority Recent Developments and Future Plans
Figure 30. Jeffers Recent Developments and Future Plans
Figure 31. Manna Pro Products Recent Developments and Future Plans
Figure 32. Merck Animal Health Recent Developments and Future Plans
Figure 33. Ourofino Recent Developments and Future Plans
Figure 34. TTK Healthcare Recent Developments and Future Plans
Figure 35. Vetoquinol Recent Developments and Future Plans
Figure 36. Virbac Recent Developments and Future Plans
Figure 37. Zoetis Recent Developments and Future Plans
Figure 38. Global Pet Anthelmintic Drugs Revenue Share by Players in 2021
Figure 39. Pet Anthelmintic Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 40. Global Top 3 Players Pet Anthelmintic Drugs Revenue Market Share in 2021
Figure 41. Global Top 10 Players Pet Anthelmintic Drugs Revenue Market Share in 2021
Figure 42. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
Figure 43. Global Pet Anthelmintic Drugs Revenue Share by Type in 2021
Figure 44. Global Pet Anthelmintic Drugs Market Share Forecast by Type (2023-2028)
Figure 45. Global Pet Anthelmintic Drugs Revenue Share by Application in 2021
Figure 46. Global Pet Anthelmintic Drugs Market Share Forecast by Application (2023-2028)
Figure 47. North America Pet Anthelmintic Drugs Sales Market Share by Type (2017-2028)
Figure 48. North America Pet Anthelmintic Drugs Sales Market Share by Application (2017-2028)
Figure 49. North America Pet Anthelmintic Drugs Revenue Market Share by Country (2017-2028)
Figure 50. United States Pet Anthelmintic Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Canada Pet Anthelmintic Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Mexico Pet Anthelmintic Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Europe Pet Anthelmintic Drugs Sales Market Share by Type (2017-2028)
Figure 54. Europe Pet Anthelmintic Drugs Sales Market Share by Application (2017-2028)
Figure 55. Europe Pet Anthelmintic Drugs Revenue Market Share by Country (2017-2028)
Figure 56. Germany Pet Anthelmintic Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. France Pet Anthelmintic Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. United Kingdom Pet Anthelmintic Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Russia Pet Anthelmintic Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Italy Pet Anthelmintic Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Asia-Pacific Pet Anthelmintic Drugs Sales Market Share by Type (2017-2028)
Figure 62. Asia-Pacific Pet Anthelmintic Drugs Sales Market Share by Application (2017-2028)
Figure 63. Asia-Pacific Pet Anthelmintic Drugs Revenue Market Share by Region (2017-2028)
Figure 64. China Pet Anthelmintic Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. Japan Pet Anthelmintic Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. South Korea Pet Anthelmintic Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. India Pet Anthelmintic Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Southeast Asia Pet Anthelmintic Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Australia Pet Anthelmintic Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. South America Pet Anthelmintic Drugs Sales Market Share by Type (2017-2028)
Figure 71. South America Pet Anthelmintic Drugs Sales Market Share by Application (2017-2028)
Figure 72. South America Pet Anthelmintic Drugs Revenue Market Share by Country (2017-2028)
Figure 73. Brazil Pet Anthelmintic Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Argentina Pet Anthelmintic Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Middle East and Africa Pet Anthelmintic Drugs Sales Market Share by Type (2017-2028)
Figure 76. Middle East and Africa Pet Anthelmintic Drugs Sales Market Share by Application (2017-2028)
Figure 77. Middle East and Africa Pet Anthelmintic Drugs Revenue Market Share by Country (2017-2028)
Figure 78. Turkey Pet Anthelmintic Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 79. Saudi Arabia Pet Anthelmintic Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 80. UAE Pet Anthelmintic Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 81. Methodology
Figure 82. Research Process and Data Source
Published By : GlobalInfoResearch
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
